You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Huhtamäki AGM | CEO's review 25.4.2024
Av Inderes
Review by CEO Charles Héaulmé from Huhtamäki's Annual General Meeting on April 25, 2024.
Herantis Pharma as an Investment | Life Science Night Dec. 2, 2024
Aiforia as an Investment | Life Science Night Dec. 2, 2024
Faron Pharmaceuticals as an Investment | Life Science Night Dec. 2, 2024
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Life Science Night | December 2, 2024
Titta på alla videor